Casodex - Nolvadex Combination

Study identifier:7054IL/0044

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Randomised, double-blind, placebo controlled, parallel-group, multicentre Phase II study to assess dose response relationship of Nolvadex (oral tablet) in prophylactic treatment of gynaecomastia and breast pain associated with CASODEX 150 mg (oral tablet), and to assess the tumour control…..

Medical condition

Gynaecomastia

Phase

Phase 2

Healthy volunteers

No

Study drug

Casodex, Tamoxifen

Sex

Male

Actual Enrollment

-

Study type

Interventional

Age

N/A

Date

Study Start Date: 01 Nov 2002
Primary Completion Date: 01 Jun 2005
Study Completion Date: 01 Aug 2005

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria